Heparin saline versus normal saline for flushing and locking peripheral venous catheters in decompensated liver cirrhosis patients: A randomized controlled trial

Medicine (United States)

Volumn 94, Issue 31, 2015, Pages

  Wang, Rui ^a   Zhang, Ming Guang ^a   Luo, Ou ^a   He, Liu ^a   Li, Jia Xin ^b   Tang, Yun Jing ^a   Luo, Yan Li ^a   Zhou, Min ^a   Tang, Li ^a   Zhang, Zong Xia ^a   Wu, Hao ^a   Chen, Xin Zu ^a   Kantarceken, Bulent ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARIN SALINE; IRRITANT AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CATHETER LEAKAGE; CATHETER OCCLUSION; CATHETER REMOVAL; CHILD PUGH SCORE; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; HUMAN; INFUSION; INJECTION SITE BLEEDING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL VENOUS CATHETER; PHASE 2 CLINICAL TRIAL (TOPIC); PHLEBITIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOCYTE FUNCTION; ADVERSE EFFECTS; BLOOD; CATHETERIZATION; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; GRAFT OCCLUSION, VASCULAR; LIVER CIRRHOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; FEMALE; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; PROTHROMBIN TIME; SINGLE-BLIND METHOD; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 84942432879     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001292     Document Type: Article

References (30)

1. Fernandez RS, Griffiths RD, Murie P. Peripheral venous catheters: a review of current practices. J Infus Nurs. 2003; 26: 388-392.
2. Myrianthefs P, Sifaki M, Samara I, et al. The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract. 2005; 11: 85-89.
3. Wang R, Luo O, He L, et al. Preservative-free 0.9% sodium chloride for flushing and locking peripheral intravenous access device: a prospective controlled trial. J Evid Based Med. 2012; 5: 205-208.
4. Muslimani AA, Ricaurte B, Daw HA. Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes. Am J Hematol. 2007; 82: 652-655.
5. Ranze O, Rakow A, Ranze P, et al. Low-dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia. Pediatr Crit Care Med. 2001; 2: 175-177.
6. Peiris K, Gee TM, Boswell TC. Bloodstream infection related to heparin infusion caused by Agrobacterium tumefaciens. J Hosp Infect. 2006; 62: 250-251.
7. Huang EY, Chen C, Abdullah F, et al. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2011; 46: 2000-2011.
8. Jairath V, Burroughs AK. Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity? Gut. 2013; 62: 479-482.
9. Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematology Am Soc Hematol Educ Program. 2012; 2012: 168-173.
10. Nelson D, Cox M. Lehninger Principles of Biochemistry. 4th ed. New York: W.H. Freeman and Company; 2005: 1216 pp. ISBN 0-7167-4339-6.
11. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol. 2010; 85: 700-706.
12. DeLoughery TG Management of acquired bleeding problems in cancer patients. Emerg Med Clin North Am. 2009; 27: 423-444.
13. Selleng K, Selleng S, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Semin Thromb Hemost. 2008; 34: 425-438.
14. Fernandez RS, Griffiths RD, Murie P. Peripheral venous catheters: a review of current practices. J Infus Nurs. 2003; 26: 388-392.
15. Bertolino G, Pitassi A, Tinelli C, et al. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews Evid Based Nurs. 2012; 9: 221-226.
16. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2011; 34(1 Suppl): S1-110.
17. Epperson EL Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites. Clin Pharm. 1984; 3: 626-629.
18. Wang XT, Li ZM, Zhong YH, et al. Effects of venous catheter locked with heparin vs. saline in China: a meta-analysis. Chin J Evid Based Med. 2011; 11: 96-100Chinese.
19. Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol. 2012; 11: 686-690.
20. Chen H, Qi X, He C, et al. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis. Thromb Res. 2013; 131: 173-177.
21. Gu JJ, He XH, Li WT, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012; 53: 862-867.
22. Zucker ML, Hagedorn CH, Murphy CA, et al. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction. Int J Lab Hematol. 2012; 34: 525-532.
23. Hepner M, Karlaftis V. Antithrombin. Methods Mol Biol. 2013; 992: 355-364.
24. Buyue Y, Misenheimer TM, Sheehan JP. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism. J Thromb Haemost. 2012; 10: 2086-2098.
25. Jacobson BF, Louw S, Büller H, et al. Venous thromboembolism: prophylactic and therapeutic practice guideline. S Afr Med J. 2013; 103 (4 Pt 2): 261-267.
26. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin. Prescrire Int. 2013; 22: 99-101103-4.
27. Nowak G. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease. Thromb Haemost. 2009; 102: 887-891.
28. Poncz M. Mechanistic basis of heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg. 2005; 17: 73-79.
29. Junqueira DR, Perini E, Penholati RR, et al. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev. 2012; 9: CD007557.
30. Wang YL, Li FM, Wang YR, et al. Observational study on heparin-inducing thrombocytopenia during venous catheter flushing and locking. W China Med J. 2013; 28: 50-53Chinese.